Goldenrod (Solidago species) is a traditional herbal remedy used primarily for urinary tract complaints, but there is no scientific evidence supporting its use for erectile dysfunction. Whilst the plant contains bioactive compounds with anti-inflammatory and diuretic properties, it is not licensed or authorised for treating ED in the UK. Erectile dysfunction is a complex condition requiring proper medical assessment, as it may indicate underlying cardiovascular or metabolic disease. This article examines goldenrod's traditional uses, safety considerations, and evidence-based treatments for erectile dysfunction, emphasising the importance of consulting healthcare professionals rather than relying on unproven herbal remedies.

What Is Goldenrod and Its Traditional Uses

Goldenrod (Solidago species) is a flowering plant native to North America and parts of Europe, characterised by its distinctive yellow plumes that appear in late summer and autumn. The plant has been used in traditional herbal medicine for centuries, primarily by Native American communities and later adopted into European folk medicine practices. Historically, goldenrod has been employed for urinary tract complaints and inflammatory conditions, earning it the German name Goldrutenkraut where it remains a recognised herbal remedy.

The plant contains various bioactive compounds including flavonoids, saponins, phenolic acids, and essential oils. These constituents are thought to contribute to its purported anti-inflammatory and diuretic properties. In the UK and EU, the traditional indication for goldenrod, as defined by the European Medicines Agency (EMA) Herbal Medicinal Products Committee (HMPC), is to increase the amount of urine to achieve flushing of the urinary tract as an adjuvant in minor urinary complaints. Traditional uses such as kidney stones or antimicrobial activity are not authorised indications and lack robust clinical evidence; any antimicrobial effects observed have been limited to laboratory studies only.

Goldenrod and erectile dysfunction: the evidence gap

Erectile dysfunction (ED) is the persistent inability to attain or maintain an erection sufficient for satisfactory sexual activity. There is no established scientific link between goldenrod and the treatment of ED, and goldenrod is not licensed or authorised for this indication in the UK. Whilst some online sources may suggest goldenrod for sexual health, this claim lacks clinical evidence and does not align with the herb's traditional therapeutic applications. Erectile dysfunction is a complex condition involving vascular, neurological, hormonal, and psychological factors. No peer-reviewed studies have demonstrated that goldenrod affects any of these mechanisms in a manner that would improve erectile function.

Patients seeking natural remedies for ED should be aware that unproven treatments may delay access to effective, evidence-based interventions and may mask serious underlying conditions. It is essential to consult a healthcare professional before using any herbal supplement, particularly for conditions like ED where underlying cardiovascular or metabolic disease may be present.

How to Use Goldenrod Safely

If individuals choose to use goldenrod for its traditional indication (flushing the urinary tract as an adjuvant in minor urinary complaints), it is important to follow safe preparation and dosing guidelines aligned with the EMA HMPC monograph and product-specific labels. Goldenrod is most commonly consumed as a herbal tea, prepared by steeping 3–5 grams of dried goldenrod herb in 150 ml of boiling water for 10–15 minutes, consumed two to four times daily. Alternatively, liquid extracts or tinctures are available; dosing depends on the extraction ratio and ethanol strength, so always follow the specific product instructions on the label.

General safety considerations include ensuring the plant material is correctly identified, as goldenrod can be confused with other yellow-flowered plants, some of which may be toxic. Commercially prepared products from reputable suppliers are preferable to wild-harvested specimens. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates herbal medicines in the UK, and patients should look for products with Traditional Herbal Registration (THR) marks where available.

Goldenrod should be used with adequate fluid intake (at least 1.5–2 litres daily), particularly given its diuretic properties. Do not use goldenrod if you have oedema (fluid retention) due to impaired heart or kidney function. It is not recommended for individuals with existing severe kidney disease without medical supervision. Pregnant and breastfeeding women should avoid goldenrod due to insufficient safety data. The herb should not be used as a substitute for antibiotics in confirmed urinary tract infections.

When to seek medical advice: If urinary symptoms worsen, fever develops, blood appears in the urine, or symptoms persist for longer than one to two weeks, consult your GP. Do not delay seeking medical assessment for urinary tract infections or other urinary conditions.

Important note regarding erectile dysfunction: Using goldenrod for ED is not supported by clinical evidence and may result in delayed diagnosis of serious underlying conditions. Men experiencing erectile difficulties should seek medical assessment rather than relying on unproven herbal remedies. Erectile dysfunction can be an early indicator of cardiovascular disease, diabetes, or hormonal imbalances that require proper investigation and management.

Potential Risks and Side Effects of Goldenrod

Whilst goldenrod is generally considered safe when used appropriately for short periods, it is not without potential adverse effects. The most commonly reported side effects are gastrointestinal disturbances, including mild nausea, stomach discomfort, and diarrhoea. These effects are typically dose-dependent and resolve upon discontinuation. The diuretic action of goldenrod may lead to increased urination and, if fluid intake is inadequate, potential dehydration.

Allergic reactions represent a significant concern, particularly for individuals with known sensitivities to plants in the Asteraceae (Compositae) family, which includes ragweed, chrysanthemums, marigolds, and daisies. Allergic manifestations may range from mild skin rashes and itching to more severe reactions. Goldenrod pollen has historically been incorrectly blamed for hay fever (the actual culprit is typically ragweed, which blooms simultaneously), but the plant itself can trigger allergic responses in susceptible individuals.

Drug interactions with goldenrod are not well established. There is a theoretical risk of additive diuretic effects if goldenrod is taken alongside prescribed diuretics, and caution is advised in patients taking lithium (as diuretics can affect lithium levels). If you are taking multiple medicines, particularly diuretics, lithium, or medications for heart or kidney conditions, consult your GP or pharmacist before using goldenrod.

When to seek urgent medical help: Call 999 or go to A&E immediately if you experience signs of a severe allergic reaction (anaphylaxis), including difficulty breathing, throat or tongue swelling, severe skin rash, dizziness, or collapse. Discontinue goldenrod and contact your GP or use NHS 111 if you experience persistent gastrointestinal symptoms, reduced urination despite increased fluid intake, or any unexpected symptoms.

Reporting side effects: If you suspect goldenrod (or any medicine) has caused a side effect, you can report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or by downloading the Yellow Card app. Reporting helps improve the safety of medicines for everyone.

For erectile dysfunction specifically, medical consultation is essential rather than self-treatment with unproven remedies, as ED may indicate serious underlying health conditions requiring investigation.

Evidence-Based Treatments for Erectile Dysfunction

Erectile dysfunction is common, affecting up to half of men aged 40–70 to some degree, with prevalence increasing with age. NICE guidance emphasises that ED should be assessed systematically, as it frequently coexists with cardiovascular disease, diabetes, hypertension, and psychological conditions. Initial management involves identifying and addressing underlying causes, lifestyle modification, and consideration of pharmacological treatments where appropriate.

Assessment and investigation

Before initiating treatment, healthcare professionals should conduct a thorough assessment including:

• Medical history: cardiovascular risk factors, diabetes, neurological conditions, hormonal disorders, psychiatric conditions, and relationship factors

• Medication review: identifying drugs that may contribute to ED (antihypertensives, antidepressants, antipsychotics, antiandrogens)

• Physical examination: blood pressure, cardiovascular assessment, genital examination where indicated (e.g., to assess for Peyronie's disease or penile deformity)

• Laboratory investigations: fasting glucose or HbA1c, lipid profile, and morning total testosterone levels (particularly if reduced libido, fatigue, or other features of hypogonadism are present). If testosterone is low or borderline, repeat the test with consideration of sex hormone-binding globulin (SHBG), free testosterone, luteinising hormone (LH), follicle-stimulating hormone (FSH), and prolactin. Thyroid function tests may be indicated if symptoms suggest thyroid disease.

When to refer or seek specialist input: Refer urgently if priapism (erection lasting more than four hours) occurs—this is a medical emergency. Consider referral for Peyronie's disease or significant penile deformity, suspected pituitary or endocrine disease, severe hypogonadism, neurological deficits, treatment failure, complex comorbidity, or high/unstable cardiovascular risk requiring assessment before resuming sexual activity.

Lifestyle modifications

Evidence supports the benefits of regular physical activity, weight loss in overweight individuals, smoking cessation, and moderation of alcohol intake. Addressing psychological factors through counselling or psychosexual therapy may be appropriate, particularly in younger men or where relationship issues are identified.

First-line pharmacological treatment

Phosphodiesterase type 5 (PDE5) inhibitors are the first-line pharmacological treatment for ED and include sildenafil, tadalafil, vardenafil, and avanafil. These medications work by enhancing the effects of nitric oxide, promoting smooth muscle relaxation in the corpus cavernosum and facilitating increased blood flow to the penis during sexual stimulation. PDE5 inhibitors are effective in approximately 70% of men with ED and are generally well-tolerated. Common side effects include headache, facial flushing, dyspepsia, and nasal congestion.

Contraindications and cautions: PDE5 inhibitors are contraindicated in men taking nitrates (e.g., glyceryl trinitrate, isosorbide mononitrate), nicorandil, or riociguat due to the risk of severe, potentially life-threatening hypotension. Patients should also be advised to avoid recreational nitrites (poppers). Caution is required in men taking alpha-blockers for benign prostatic hyperplasia or hypertension, as concurrent use may cause symptomatic hypotension; dose adjustment and timing may be necessary. PDE5 inhibitors should be used with caution in men with anatomical penile abnormalities, bleeding disorders, active peptic ulceration, severe hepatic impairment, or recent stroke or myocardial infarction.

In the UK, sildenafil 50 mg is available from pharmacies without prescription (as a P medicine) following a structured consultation and cardiovascular risk assessment by the pharmacist. Patients should always use licensed products and follow the prescriber's or pharmacist's advice.

Alternative and second-line treatments

Options include vacuum erection devices, intracavernosal injections (alprostadil), intraurethral alprostadil, and penile prosthesis surgery for refractory cases. Testosterone replacement therapy may be indicated in men with confirmed hypogonadism following specialist assessment, but it is not effective for ED in men with normal testosterone levels and should not be used as monotherapy for ED without hypogonadism.

Men experiencing erectile difficulties should consult their GP for proper assessment rather than pursuing unproven herbal remedies. Early medical evaluation enables identification of treatable underlying conditions and access to effective, evidence-based treatments that can significantly improve quality of life and sexual function. For further information, see the NHS website and NICE Clinical Knowledge Summaries on erectile dysfunction.

Frequently Asked Questions